Pharming (PHAR) Change in Inventory (2020 - 2025)
Pharming's (PHAR) quarterly Change in Inventory came in at -$1.3 million in Q4 2025, down 156.06% YoY from $2.3 million in Q4 2024, and down 156.06% on a QoQ basis from -$503000.0 in Q4 2024.
Pharming (PHAR) Change in Inventory (2020 - 2025) Analysis & Trends
Pharming (PHAR) has 6 years of Change in Inventory data on file, last reported at -$1.3 million in Q4 2025.
- Quarterly Change in Inventory fell 156.06% year-over-year to -$1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.4 million (down 5.11% YoY) and the FY2025 annual result came in at -$1.3 million, down 156.06% from the prior year.
- Change in Inventory slipped to -$1.3 million in Q4 2025, from -$503000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $423000.0 in Q3 2022 to a low of -$14.4 million in Q4 2023.
- A 5-year average of -$3.3 million and a median of -$1.0 million in 2021 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory slumped 11709.71% — and 2022, when it jumped 152.9%.
- Tracing PHAR's Change in Inventory over 5 years: stood at -$608000.0 in 2021, then sank by 277.8% to -$2.3 million in 2022, then sank by 528.38% to -$14.4 million in 2023, then jumped by 96.52% to -$503000.0 in 2024, then slumped by 156.06% to -$1.3 million in 2025.
- The last three Change in Inventory figures came in at -$1.3 million (Q4 2025), -$503000.0 (Q4 2024), and -$2.1 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.29 Mn |
| Dec 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | -503,000.00 |
| Dec 31, 2024 | -503,000.00 |
| Sep 30, 2024 | -2.13 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Dec 31, 2023 | -14.43 Mn |
| Dec 31, 2023 | -14.43 Mn |
| Sep 30, 2023 | -396,000.00 |
| Sep 30, 2023 | -396,000.00 |
| Jun 30, 2023 | -10.72 Mn |
| Jun 30, 2023 | -10.72 Mn |
| Dec 31, 2022 | -2.30 Mn |
| Dec 31, 2022 | -2.30 Mn |
| Sep 30, 2022 | 423,000.00 |
| Sep 30, 2022 | 423,000.00 |
| Dec 31, 2021 | -608,000.00 |
| Dec 31, 2021 | -608,000.00 |
| Sep 30, 2021 | -799,556.80 |
| Sep 30, 2021 | -799,556.80 |